Elevated HAUS1 expression (red and green, Figure 6(a)) in the IDH1 mutation group indicated a dismal survival outcome, implying that HAUS1 was a significant prognostic factor for patients with glioma with the corresponding IDH1 genotypes (P < 0.001). Here, IDH1 is linked to central nervous system cancer.